Please join us for our upcoming webinar:
Risk-Based Monitoring for All – How the ICH E6 (R2) has given clinical development organizations the perfect opportunity to improve and lower costs through adoption of RBM and Centralized Monitoring
For this webinar, CluePoints’ Chief Operations Officer, Steve Young, is teaming up with Jason W. Raines, MS, MPH, Head of Biometrics Data Sciences and Operations at Biogen. You will learn first-hand how to embrace the paradigm shift that is going on within the industry. No matter the size of your organization – small, mid-size or large – listen to pragmatic advice and hear about powerful case studies demonstrating the blend of change management and technology that will work for you. Two industry thought leaders and RBM experts will guide you through a Risk-Based Approach to managing studies, as advocated by the regulators, from Pre–Study Risk Assessment right through to Database Lock and Submission.
Delegates will benefit from the following:
- Advice to determine the right scale of RBM adoption – including a sensible step by step approach
- How to ensure cross-functional adoption of the right approach
- Seeing what others have done in terms of methodology and technology adoption
- An overview of how to improve data quality and determine tangible cost savings through RBM adoption
- The future of RBM – what can Sponsors and CROs expect in the future
